Stay updated on MDMA Impact on Startle Response Clinical Trial
Sign up to get notified when there's something new on the MDMA Impact on Startle Response Clinical Trial page.

Latest updates to the MDMA Impact on Startle Response Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.5.4 has been added to the history and the previous entry v3.5.3 has been removed, updating the page's revision history to reflect the latest update.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedResilient Pharmaceuticals has been added as the sponsor, and Lykos Therapeutics has been removed. This reflects a change in the sponsor/Responsible Party for the study.SummaryDifference0.2%

- Check27 days agoChange DetectedThe page’s revision/version identifier was updated from v3.5.2 to v3.5.3. This appears to be a site release/version change rather than an update to the trial’s recorded data.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3 from the history.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page history shows a new revision labeled v3.4.3 replacing the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to MDMA Impact on Startle Response Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MDMA Impact on Startle Response Clinical Trial page.